title: Differential effect of etanercept on cutaneous and joint lesions in psoriatic arthritis.
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Mizote
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nakahara
authors.forename: Chikage
authors.initials: C
authors.lastname: Mitoma
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Nakao
authors.forename: Hiroki
authors.initials: H
authors.lastname: Mitoma
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Moroi
authors.forename: Masutaka
authors.initials: M
authors.lastname: Furue
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology / Q000627:therapeutic use*; D007596:Joints / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects / Q000473:pathology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept